Cargando…

Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer

Reports demonstrate the role of M-CSF (CSF1) in tumor progression in mouse models as well as the prognostic value of macrophage numbers in breast cancer patients. Recently, a subset of CD14+ monocytes expressing the Tie2 receptor, once thought to be predominantly expressed on endothelial cells, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Forget, Mary A., Voorhees, Jeffrey L., Cole, Sara L., Dakhlallah, Duaa, Patterson, Ivory L., Gross, Amy C., Moldovan, Leni, Mo, Xiaokui, Evans, Randall, Marsh, Clay B., Eubank, Tim D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043882/
https://www.ncbi.nlm.nih.gov/pubmed/24892425
http://dx.doi.org/10.1371/journal.pone.0098623
_version_ 1782319018255843328
author Forget, Mary A.
Voorhees, Jeffrey L.
Cole, Sara L.
Dakhlallah, Duaa
Patterson, Ivory L.
Gross, Amy C.
Moldovan, Leni
Mo, Xiaokui
Evans, Randall
Marsh, Clay B.
Eubank, Tim D.
author_facet Forget, Mary A.
Voorhees, Jeffrey L.
Cole, Sara L.
Dakhlallah, Duaa
Patterson, Ivory L.
Gross, Amy C.
Moldovan, Leni
Mo, Xiaokui
Evans, Randall
Marsh, Clay B.
Eubank, Tim D.
author_sort Forget, Mary A.
collection PubMed
description Reports demonstrate the role of M-CSF (CSF1) in tumor progression in mouse models as well as the prognostic value of macrophage numbers in breast cancer patients. Recently, a subset of CD14+ monocytes expressing the Tie2 receptor, once thought to be predominantly expressed on endothelial cells, has been characterized. We hypothesized that increased levels of CSF1 in breast tumors can regulate differentiation of Tie2- monocytes to a Tie2+ phenotype. We treated CD14+ human monocytes with CSF1 and found a significant increase in CD14+/Tie2+ positivity. To understand if CSF1-induced Tie2 expression on these cells improved their migratory ability, we pre-treated CD14+ monocytes with CSF1 and used Boyden chemotaxis chambers to observe enhanced response to angiopoietin-2 (ANG2), the chemotactic ligand for the Tie2 receptor. We found that CSF1 pre-treatment significantly augmented chemotaxis and that Tie2 receptor upregulation was responsible as siRNA targeting Tie2 receptor abrogated this effect. To understand any augmented angiogenic effect produced by treating these cells with CSF1, we cultured human umbilical vein endothelial cells (HUVECs) with conditioned supernatants from CSF1-pre-treated CD14+ monocytes for a tube formation assay. While supernatants from CSF1-pre-treated TEMs increased HUVEC branching, a neutralizing antibody against the CSF1R abrogated this activity, as did siRNA against the Tie2 receptor. To test our hypothesis in vivo, we treated PyMT tumor-bearing mice with CSF1 and observed an expansion in the TEM population relative to total F4/80+ cells, which resulted in increased angiogenesis. Investigation into the mechanism of Tie2 receptor upregulation on CD14+ monocytes by CSF1 revealed a synergistic contribution from the PI3 kinase and HIF pathways as the PI3 kinase inhibitor LY294002, as well as HIF-1α-deficient macrophages differentiated from the bone marrow of HIF-1α(fl/fl)/LysMcre mice, diminished CSF1-stimulated Tie2 receptor expression.
format Online
Article
Text
id pubmed-4043882
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40438822014-06-09 Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer Forget, Mary A. Voorhees, Jeffrey L. Cole, Sara L. Dakhlallah, Duaa Patterson, Ivory L. Gross, Amy C. Moldovan, Leni Mo, Xiaokui Evans, Randall Marsh, Clay B. Eubank, Tim D. PLoS One Research Article Reports demonstrate the role of M-CSF (CSF1) in tumor progression in mouse models as well as the prognostic value of macrophage numbers in breast cancer patients. Recently, a subset of CD14+ monocytes expressing the Tie2 receptor, once thought to be predominantly expressed on endothelial cells, has been characterized. We hypothesized that increased levels of CSF1 in breast tumors can regulate differentiation of Tie2- monocytes to a Tie2+ phenotype. We treated CD14+ human monocytes with CSF1 and found a significant increase in CD14+/Tie2+ positivity. To understand if CSF1-induced Tie2 expression on these cells improved their migratory ability, we pre-treated CD14+ monocytes with CSF1 and used Boyden chemotaxis chambers to observe enhanced response to angiopoietin-2 (ANG2), the chemotactic ligand for the Tie2 receptor. We found that CSF1 pre-treatment significantly augmented chemotaxis and that Tie2 receptor upregulation was responsible as siRNA targeting Tie2 receptor abrogated this effect. To understand any augmented angiogenic effect produced by treating these cells with CSF1, we cultured human umbilical vein endothelial cells (HUVECs) with conditioned supernatants from CSF1-pre-treated CD14+ monocytes for a tube formation assay. While supernatants from CSF1-pre-treated TEMs increased HUVEC branching, a neutralizing antibody against the CSF1R abrogated this activity, as did siRNA against the Tie2 receptor. To test our hypothesis in vivo, we treated PyMT tumor-bearing mice with CSF1 and observed an expansion in the TEM population relative to total F4/80+ cells, which resulted in increased angiogenesis. Investigation into the mechanism of Tie2 receptor upregulation on CD14+ monocytes by CSF1 revealed a synergistic contribution from the PI3 kinase and HIF pathways as the PI3 kinase inhibitor LY294002, as well as HIF-1α-deficient macrophages differentiated from the bone marrow of HIF-1α(fl/fl)/LysMcre mice, diminished CSF1-stimulated Tie2 receptor expression. Public Library of Science 2014-06-03 /pmc/articles/PMC4043882/ /pubmed/24892425 http://dx.doi.org/10.1371/journal.pone.0098623 Text en © 2014 Forget et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Forget, Mary A.
Voorhees, Jeffrey L.
Cole, Sara L.
Dakhlallah, Duaa
Patterson, Ivory L.
Gross, Amy C.
Moldovan, Leni
Mo, Xiaokui
Evans, Randall
Marsh, Clay B.
Eubank, Tim D.
Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer
title Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer
title_full Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer
title_fullStr Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer
title_full_unstemmed Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer
title_short Macrophage Colony-Stimulating Factor Augments Tie2-Expressing Monocyte Differentiation, Angiogenic Function, and Recruitment in a Mouse Model of Breast Cancer
title_sort macrophage colony-stimulating factor augments tie2-expressing monocyte differentiation, angiogenic function, and recruitment in a mouse model of breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043882/
https://www.ncbi.nlm.nih.gov/pubmed/24892425
http://dx.doi.org/10.1371/journal.pone.0098623
work_keys_str_mv AT forgetmarya macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT voorheesjeffreyl macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT colesaral macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT dakhlallahduaa macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT pattersonivoryl macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT grossamyc macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT moldovanleni macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT moxiaokui macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT evansrandall macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT marshclayb macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer
AT eubanktimd macrophagecolonystimulatingfactoraugmentstie2expressingmonocytedifferentiationangiogenicfunctionandrecruitmentinamousemodelofbreastcancer